Literature DB >> 21482730

Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Teun Bousema1, Chris Drakeley.   

Abstract

Malaria remains a major cause of morbidity and mortality in the tropics, with Plasmodium falciparum responsible for the majority of the disease burden and P. vivax being the geographically most widely distributed cause of malaria. Gametocytes are the sexual-stage parasites that infect Anopheles mosquitoes and mediate the onward transmission of the disease. Gametocytes are poorly studied despite this crucial role, but with a recent resurgence of interest in malaria elimination, the study of gametocytes is in vogue. This review highlights the current state of knowledge with regard to the development and longevity of P. falciparum and P. vivax gametocytes in the human host and the factors influencing their distribution within endemic populations. The evidence for immune responses, antimalarial drugs, and drug resistance influencing infectiousness to mosquitoes is reviewed. We discuss how the application of molecular techniques has led to the identification of submicroscopic gametocyte carriage and to a reassessment of the human infectious reservoir. These components are drawn together to show how control measures that aim to reduce malaria transmission, such as mass drug administration and a transmission-blocking vaccine, might better be deployed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482730      PMCID: PMC3122489          DOI: 10.1128/CMR.00051-10

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  517 in total

1.  Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission.

Authors:  Amel Abdel-Wahab; Abdel-Muhsin A Abdel-Muhsin; Eltayeb Ali; Suad Suleiman; Salah Ahmed; David Walliker; Hamza A Babiker
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

2.  Relative increase in the prevalence of Plasmodium falciparum some years after the beginning of a house-spraying campaign in Netherlands New Guinea.

Authors:  D METSELAAR
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-11       Impact factor: 2.184

3.  Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine.

Authors:  J M Govere; D N Durrheim; N M Mngomezulu; K Barnes; B Sharp
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Nov-Dec       Impact factor: 2.184

4.  Observations on the periodicity of Plasmodium falciparum gametocytes in natural human infections.

Authors:  S M Magesa; Y K Mdira; J A Akida; I C Bygbjerg; P H Jakobsen
Journal:  Acta Trop       Date:  2000-10-02       Impact factor: 3.112

5.  Development of a method for the in vitro production of Plasmodium vivax ookinetes.

Authors:  N Suwanabun; J Sattabongkot; T Tsuboi; M Torii; N Maneechai; N Rachapaew; N Yim-amnuaychok; V Punkitchar; R E Coleman
Journal:  J Parasitol       Date:  2001-08       Impact factor: 1.276

6.  Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya.

Authors:  Philip Bejon; Thomas N Williams; Anne Liljander; Abdisalan M Noor; Juliana Wambua; Edna Ogada; Ally Olotu; Faith H A Osier; Simon I Hay; Anna Färnert; Kevin Marsh
Journal:  PLoS Med       Date:  2010-07-06       Impact factor: 11.069

7.  Plasmodium falciparum gametocytaemia with chloroquine chemotherapy in persistent malaria in an endemic area of India.

Authors:  P K Kar; V K Dua; N C Gupta; Ashish Gupta; A P Dash
Journal:  Indian J Med Res       Date:  2009-03       Impact factor: 2.375

8.  Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand.

Authors:  Russell E Coleman; Chalermpon Kumpitak; Alongkot Ponlawat; Nongnuj Maneechai; Vichit Phunkitchar; Nattawan Rachapaew; Gabriella Zollner; Jetsumon Sattabongkot
Journal:  J Med Entomol       Date:  2004-03       Impact factor: 2.278

9.  Effectiveness of malaria control during changing climate conditions in Eritrea, 1998-2003.

Authors:  Patricia M Graves; Daniel E Osgood; Madeleine C Thomson; Kiros Sereke; Afwerki Araia; Mehari Zerom; Pietro Ceccato; Michael Bell; John Del Corral; Shashu Ghebreselassie; Eugene P Brantly; Tewolde Ghebremeskel
Journal:  Trop Med Int Health       Date:  2008-02       Impact factor: 2.622

10.  The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.

Authors:  Carlos A Guerra; Priscilla W Gikandi; Andrew J Tatem; Abdisalan M Noor; Dave L Smith; Simon I Hay; Robert W Snow
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  363 in total

Review 1.  Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

Authors:  Benjamin Blasco; Didier Leroy; David A Fidock
Journal:  Nat Med       Date:  2017-08-04       Impact factor: 53.440

2.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.

Authors:  Sophie H Adjalley; Geoffrey L Johnston; Tao Li; Richard T Eastman; Eric H Ekland; Abraham G Eappen; Adam Richman; B Kim Lee Sim; Marcus C S Lee; Stephen L Hoffman; David A Fidock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

Review 3.  Sexual development in Plasmodium parasites: knowing when it's time to commit.

Authors:  Gabrielle A Josling; Manuel Llinás
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

4.  Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.

Authors:  Leonardo Lucantoni; David A Fidock; Vicky M Avery
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.

Authors:  Asikiya Walcourt; Joseph Kurantsin-Mills; John Kwagyan; Babafemi B Adenuga; Danuta S Kalinowski; David B Lovejoy; Darius J R Lane; Des R Richardson
Journal:  J Inorg Biochem       Date:  2013-08-26       Impact factor: 4.155

6.  A Direct from Blood Reverse Transcriptase Polymerase Chain Reaction Assay for Monitoring Falciparum Malaria Parasite Transmission in Elimination Settings.

Authors:  Brian J Taylor; Kjerstin Lanke; Shanna L Banman; Isabelle Morlais; Merribeth J Morin; Teun Bousema; Sanna R Rijpma; Stephanie K Yanow
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.

Authors:  Abel Kakuru; Prasanna Jagannathan; Emmanuel Arinaitwe; Humphrey Wanzira; Mary Muhindo; Victor Bigira; Emmanuel Osilo; Jaco Homsy; Moses R Kamya; Jordan W Tappero; Grant Dorsey
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

Review 8.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

9.  Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.

Authors:  Naman K Shah; Allan Schapira; Jonathan J Juliano; Bina Srivastava; Pia D M MacDonald; Charles Poole; Anup Anvikar; Steven R Meshnick; Neena Valecha; Neelima Mishra
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

10.  Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes.

Authors:  Sujata Balasubramanian; Rifat S Rahman; Chanthap Lon; Christian Parobek; Ratawan Ubalee; Nicholas Hathaway; Worachet Kuntawunginn; Mok My; Dav Vy; Jeremy Saxe; Charlotte Lanteri; Feng-Chang Lin; Michele Spring; Steven R Meshnick; Jonathan J Juliano; David L Saunders; Jessica T Lin
Journal:  J Infect Dis       Date:  2020-01-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.